There isn’t a single “meningitis vaccine.” Because bacterial meningitis can be caused by several different types of bacteria, multiple vaccines work together to provide protection. The three main vaccines target meningococcal bacteria, pneumococcal bacteria, and Haemophilus influenzae type b (Hib). Which ones you or your child need depends on age, health status, and risk factors.
The Three Bacteria Behind Most Vaccine-Preventable Meningitis
Bacterial meningitis is an infection of the tissue surrounding the brain and spinal cord. It can become life-threatening within hours. Three families of bacteria cause the vast majority of cases that vaccines can prevent: meningococcal bacteria (Neisseria meningitidis), pneumococcal bacteria (Streptococcus pneumoniae), and Haemophilus influenzae type b. Each requires its own vaccine because the immune system recognizes them differently.
Meningococcal Vaccines: The Ones Most People Mean
When people say “the meningitis vaccine,” they’re usually referring to meningococcal vaccines. Meningococcal bacteria come in multiple serogroups, labeled by letters. In the United States, three types of meningococcal vaccine are available:
- MenACWY (conjugate vaccine): protects against serogroups A, C, W, and Y
- MenB (recombinant protein vaccine): protects against serogroup B
- MenABCWY (pentavalent vaccine): covers all five serogroups in one shot, approved by the FDA in late 2024 under the brand name Penbraya
MenACWY is the standard shot recommended for all preteens and teens. MenB is handled differently. Rather than a blanket recommendation, the CDC recommends a shared decision between adolescents (or their parents) and their doctor about whether the serogroup B vaccine makes sense for them individually. The pentavalent MenABCWY vaccine simplifies things by combining both into a single product, though it’s still relatively new.
How Well They Work
A large Italian study of nearly 1.7 million children found the serogroup B vaccine to be roughly 91% to 95% effective against invasive meningococcal disease in fully immunized children. MenACWY vaccines have similarly strong effectiveness in the first few years after vaccination, though protection fades over time, which is why a booster is needed.
The Recommended Schedule
For MenACWY, all 11- to 12-year-olds should get the first dose. Because protection wanes, a booster is recommended at age 16. If the first dose was delayed until ages 13 through 15, the booster should be given between ages 16 and 18.
For MenB, the preferred window is ages 16 through 18, which lines up with the period of highest risk (late high school and college years). The standard series is two doses given six months apart. Students heading to college with less than six months before move-in can get a three-dose series on an accelerated timeline to build protection faster.
The Hib Vaccine: Protection for Infants
Before effective vaccines existed, Haemophilus influenzae type b was the leading cause of bacterial meningitis in children under five. The Hib vaccine dramatically changed that. It’s given as part of the routine infant immunization schedule, starting at two months of age.
The number of doses in the primary series depends on the specific product used. One version requires three doses at ages 2, 4, and 6 months. Another requires just two doses at 2 and 4 months. Both types call for a booster between 12 and 15 months. Some combination vaccines bundle the Hib vaccine with other routine childhood shots so that fewer injections are needed overall.
Hib vaccines use a conjugate design. The bacteria’s outer coating (a sugar molecule called a polysaccharide) is too simple for a young child’s immune system to recognize on its own. By chemically linking it to a protein carrier, the vaccine transforms it into something the immune system can mount a strong, lasting response against.
Pneumococcal Vaccines
Pneumococcal bacteria are best known for causing pneumonia and ear infections, but they also cause meningitis. Pneumococcal conjugate vaccines (PCVs) protect against multiple strains of the bacteria. Current versions include PCV15 and PCV20, which cover 15 and 20 strains respectively. These are recommended for all infants as part of routine childhood immunizations, and certain versions are also recommended for older adults and people with specific health conditions.
Who Needs Extra Protection
Some people face a much higher risk of meningococcal disease and need additional doses beyond the standard schedule. This includes people who have a functioning spleen that’s been removed or doesn’t work properly (asplenia), those with persistent deficiencies in part of their immune system called the complement system, people taking medications that inhibit complement, and microbiologists who routinely handle meningococcal bacteria in the lab.
For these groups, a MenB booster is recommended at least one year after finishing the primary series, with additional boosters every two to three years for as long as the increased risk continues. MenACWY boosters follow a similar ongoing schedule for high-risk individuals.
Common Side Effects
Meningococcal vaccines are well tolerated. In children aged 2 to 10, the most common reactions are pain, redness, and firmness at the injection site, along with irritability and sleepiness. In adolescents and adults, injection site pain, headache, redness, and muscle aches are the most frequently reported effects. These typically resolve within a day or two.
Serious reactions are rare. A review of over 2,600 post-vaccination reports for one MenACWY vaccine over a five-year period identified 67 serious reports. The most common serious events were fainting (vasovagal syncope, often a response to the needle itself rather than the vaccine) and severe allergic reactions (anaphylaxis), which occurred in seven cases across the entire reporting period. No safety signals beyond what was seen in clinical trials emerged from that surveillance.
Choosing Between Separate and Combined Vaccines
The approval of Penbraya, the pentavalent vaccine covering serogroups A, B, C, W, and Y, offers a practical advantage. Previously, protecting against all five serogroups required two separate vaccine products on potentially different schedules. A combined vaccine means fewer total injections. Your doctor or pharmacist can help determine whether the pentavalent option or the individual vaccines are the better fit based on what doses you’ve already received and your age.